ABSTRACT
MS is essentially a mechanical problem requiring intervention in advanced stages of disease. In the early stages and those waiting for intervention, medical therapy with β- blockers may be helpful. Diuretics should not be presribed as a routine, but given to only those patients who are significantly symptomatic. Secondary prevention for rheumatic fever is an essential component of rheumatic MS. IE prophylaxis is reserved for high risk patients. Disease modifying therapies especially with statins need further studies.
